All 25 BBH (VANECK BIOTECH ETF) Holdings
There are 25 BBH holdings. Top 10 companies weight: 69.95%.
Total Market Cap: $1.05T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (25 stocks) | +25.82% | 23.69 | 18.12 | 0.53 | +15.64% | +10.46% | 0.65 | ||||||||||
1 | AMGN | Amgen Inc | 15.13% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
2 | GILD | Gilead Sciences Inc | 12.67% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
3 | VRTX | Vertex Pharmaceuticals Inc | 9.07% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
4 | REGN | Regeneron Pharmaceuticals Inc | 6.18% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
5 | RVMD | Revolution Medicines Inc Ordinary Shares | 5.25% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
6 | NTRA | Natera Inc | 4.98% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
7 | ARGX | Argenx Se Adr | 4.85% | $846.19 | $57B | Biotechnology | Healthcare | N/A | 24.30 | 32.89 | 0.21 | N/A | N/A | 79 | +24.69% | $1.06K | +21.54% | 0.46 |
8 | IQV | Iqvia Holdings Inc | 4.50% | $203.95 | $35B | Diagnostics & Research | Healthcare | +30.82% | 25.28 | 16.13 | 2.67 | N/A | N/A | 75 | +13.75% | $232 | -3.45% | 1.02 |
9 | ALNY | Alnylam Pharmaceuticals Inc | 3.82% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
10 | BIIB | Biogen Inc | 3.50% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
11 | MRNA | Moderna Inc | 3.46% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
12 | ILMN | Illumina Inc | 3.30% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
13 | ONC | Beone Medicines Ltd Adr | 2.85% | $310.58 | $36B | Biotechnology | Healthcare | N/A | 69.54 | 47.39 | N/A | N/A | N/A | 81 | +33.57% | $415 | +0.26% | 0.54 |
14 | UTHR | United Therapeutics Corp | 2.84% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
15 | INSM | Insmed Inc | 2.66% | $107.02 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +83.50% | $196 | +32.69% | 0.77 |
16 | INCY | Incyte Corp | 2.49% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
17 | NBIX | Neurocrine Biosciences Inc | 2.06% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
18 | BNTX | Biontech Se Adr | 1.95% | $92.16 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.63% | $122 | -18.34% | 0.94 |
19 | ICLR | Icon Plc | 1.91% | $166.18 | $13B | Diagnostics & Research | Healthcare | -0.99% | 57.45 | 16.26 | 0.54 | N/A | N/A | 63 | +9.41% | $182 | -4.94% | 1.05 |
20 | TECH | Bio-techne Corp | 1.54% | $71.64 | $11B | Biotechnology | Healthcare | -10.07% | 101.96 | 34.48 | 0.96 | N/A | N/A | 58 | -2.29% | $70 | -8.73% | 1.13 |
21 | CRL | Charles River Laboratories International Inc | 1.51% | $219.57 | $11B | Diagnostics & Research | Healthcare | N/A | N/A | 20.16 | N/A | N/A | N/A | 75 | +5.17% | $231 | -10.66% | 1.38 |
22 | BMRN | Biomarin Pharmaceutical Inc | 1.34% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
23 | QGEN | Qiagen Nv | 1.06% | $40.48 | $8.51B | Diagnostics & Research | Healthcare | +3.15% | 20.03 | 12.94 | 0.05 | N/A | N/A | 70 | +8.87% | $44 | -4.19% | 0.50 |
24 | TEM | Tempus Ai Inc Class A Common Stock | 1.04% | $48.41 | $10B | Health Information Services | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 65 | +38.53% | $67 | 0.00% | 2.68 |
25 | n/a | Us Dollar | 0.05% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BBH (VANECK BIOTECH ETF) Sector Allocation
HEALTHCARE
100.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%